Condition: Rhegmatogenous Retinal Detachment - Macula Off · Sponsor: ONL Therapeutics
The goal of this Phase 2 clinical trial is to learn about ONL1204 Ophthalmic Solution in terms of safety and how well the drug works in patients that have a macula-off (central point of vision) rhegmatogenous retinal detachment (RRD). The main questions it aims to answer are: * Does ONL1204 improve vision in macula-off RRD patients when used before retinal detachment repair surgery compared to patients that have surgery alone? * Is ONL1204 safe to use as an add-on drug before retinal repair surgery? Researchers will observe patients that receive two different dosages of ONL1204 Ophthalmic Solution (50 µg or 200 µg) compared to current standard therapy (no treatment) to see if there are differences in vision and safety outcomes.
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| Associated Retina Consultants | Phoenix, Arizona, United States | — |
| Retina Associates SW PC | Tucson, Arizona, United States | — |
| Win Retina | Arcadia, California, United States | — |
| Global Research Management, Inc. | Glendale, California, United States | — |
| Salehi Retina Institute, Inc. | Huntington Beach, California, United States | — |
| Florida Retina Institute | Jacksonville, Florida, United States | — |
| Florida Retina Consultants | Lakeland, Florida, United States | — |
| Retina Specialty Institute | Pensacola, Florida, United States | — |
| Sarasota Retina Institute | Sarasota, Florida, United States | — |
| Retina Vitreous Associates of Florida | St. Petersburg, Florida, United States | — |
| Retina Specialists of Tampa | Wesley Chapel, Florida, United States | — |
| Marietta Eye Clinic | Marietta, Georgia, United States | — |
+ 24 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.